Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  liposomal cytarabine
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-13 of 13 for your search:
Start Over
Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Leptomeningeal Metastases of Breast Cancer Versus no Intrathecal Treatment
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: DEPOSEIN-1008, NCT01645839
High-Dose Sequential Chemoimmunotherapy for B-Cell Lymphomas With Central Nervous System Involvement
Phase: Phase II
Type: Treatment
Status: Active
Age: 19 to 65
Sponsor: Other
Protocol IDs: SCNSL1, IIL-SCNSL-1, NCT00801216
High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: NHL-ZNS-Rezidiv, NCT01148173
CHemoImmunotherapy With Early Central Nervous System (CNS) Prophylaxis
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 64
Sponsor: Other
Protocol IDs: NLG-LBC-05, NCT01325194
Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma
Phase: Phase II
Type: Treatment
Status: Active
Age: 0 to 19
Sponsor: Other
Protocol IDs: MUV-MEMMAT-01, NCT01356290
Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children
Phase: Phase II
Type: Treatment
Status: Active
Age: Less than 18
Sponsor: Other
Protocol IDs: CILI, 2011-002622-48, NCT01593488
Personalized Therapy of Precursor Lymphoid Neoplasms
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: PALG ALL6, NCT01665001
Treatment for Advanced B-Cell Lymphoma
Phase: Phase II
Type: Treatment
Status: Active
Age: 3 to 31
Sponsor: Other
Protocol IDs: NYMC-157, L 10,753, NCT01859819
Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: 130934, NCT02043587
A Trial on a New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: IELSG42, NCT02329080
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
Phase: Phase II
Type: Treatment
Status: Active
Age: 3 to 31
Sponsor: Other
Protocol IDs: L-11,392, NCT02393157
Start Over